Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Insulin Detemir in Combination With OADs in Type 2 Diabetes Mellitus

NCT00592527 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00592527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00592527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Insulin Detemir in Combination With OADs in Type 2 Diabetes Mellitus
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2004
Completion date
December 31, 2004
Enrollment
132 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2